Wallkill BioPharma Inc.
Biotechnology company · Wilmington, Delaware, United States
Wallkill BioPharma Inc. is a biotechnology company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $207,513 sold in a notice filed in 2018.
Wallkill BioPharma at a glance
What does Wallkill BioPharma do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $207,513 sold (2018).
Frequently asked questions about Wallkill BioPharma
Where is Wallkill BioPharma headquartered?
Wallkill BioPharma Inc. is headquartered in Wilmington, Delaware, United States.
What does Wallkill BioPharma do?
Wallkill BioPharma Inc. is a biotechnology company.
When was Wallkill BioPharma founded?
The earliest incorporation on record for Wallkill BioPharma Inc. is in 2017, according to public company registers.
Similar companies
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- OpiAID, LLCWilmington, North Carolina, United States
- Synnovation Therapeutics, Inc.Wilmington, Delaware, United States
- Treadwell CorporationWilmington, North Carolina, United States
- NiKang Therapeutics, Inc.Wilmington, Delaware, United States
- GPN Vaccines, Inc.Wilmington, Delaware, United States
- Advanced Materials Technology, Inc.Wilmington, Delaware, United States
- Compact Membrane Systems, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences